This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...